User profiles for E. Crisafulli
Ernesto Crisafulli, MD PhDUniversity of Verona - Department of Medicine Verified email at univr.it Cited by 3835 |
[HTML][HTML] Measures of dyspnea in pulmonary rehabilitation
E Crisafulli, EM Clini - Multidisciplinary respiratory medicine, 2010 - Springer
Dyspnea is the main symptom perceived by patients affected by chronic respiratory diseases.
It derives from a complex interaction of signals arising in the central nervous system, which …
It derives from a complex interaction of signals arising in the central nervous system, which …
[HTML][HTML] Management of severe acute exacerbations of COPD: an updated narrative review
E Crisafulli, E Barbeta, A Ielpo, A Torres - Multidisciplinary respiratory …, 2018 - Springer
Background Patients with chronic obstructive pulmonary disease (COPD) may experience
an acute worsening of respiratory symptoms that results in additional therapy; this event is …
an acute worsening of respiratory symptoms that results in additional therapy; this event is …
Respiratory muscles training in COPD patients
E Crisafulli, S Costi, LM Fabbri… - International journal of …, 2007 - Taylor & Francis
It is known that respiratory muscles undergo adaptation in response to overload stimuli
during exercise training in stable COPD patients, thus resulting in significant increase of …
during exercise training in stable COPD patients, thus resulting in significant increase of …
Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation
E Crisafulli, S Costi, F Luppi, G Cirelli, C Cilione… - Thorax, 2008 - thorax.bmj.com
… E Crisafulli1, … The diagnosis of each patient was recorded on an electronic database
according to the codes of the International Classification of Diseases, version 9-CM.22 …
according to the codes of the International Classification of Diseases, version 9-CM.22 …
Efficacy of standard rehabilitation in COPD outpatients with comorbidities
E Crisafulli, P Gorgone, B Vagaggini… - European …, 2010 - Eur Respiratory Soc
A prospective study was performed to confirm the prevalence pattern of the most frequent co-morbidities
and to evaluate whether characteristics of patients, specific comorbidities and …
and to evaluate whether characteristics of patients, specific comorbidities and …
[HTML][HTML] Chronic fatigue syndrome: an emerging sequela in COVID-19 survivors?
SARS-CoV-2 survivors may report persistent symptoms that resemble myalgic
encephalomyelitis/chronic fatigue syndrome (ME/CFS). We explored (a) ME/CFS-like symptom …
encephalomyelitis/chronic fatigue syndrome (ME/CFS). We explored (a) ME/CFS-like symptom …
Prevalence of small-airway dysfunction among COPD patients with different GOLD stages and its role in the impact of disease
E Crisafulli, R Pisi, M Aiello, M Vigna, P Tzani, A Torres… - Respiration, 2016 - karger.com
Background: In chronic obstructive pulmonary disease (COPD) patients, small-airway
dysfunction (SAD) is considered a functional hallmark of disease. However, the exact role of SAD …
dysfunction (SAD) is considered a functional hallmark of disease. However, the exact role of SAD …
Effects of unsupported upper extremity exercise training in patients with COPD: a randomized clinical trial
S Costi, E Crisafulli, F Degli Antoni, C Beneventi… - Chest, 2009 - Elsevier
… Crisafulli has made substantial contributions to conception and design, acquisition of data,
and analysis and interpretation of data. Ms. Degli Antoni has made substantial contributions …
and analysis and interpretation of data. Ms. Degli Antoni has made substantial contributions …
Pneumonic and nonpneumonic exacerbations of COPD: inflammatory response and clinical characteristics
A Huerta, E Crisafulli, R Menéndez, R Martínez… - Chest, 2013 - Elsevier
… , CAP, and AECOPD and sepsis and septic shock definitions are provided in e-Appendix 1.
… measurement of early inflammatory response (e-Table 2, Fig 3, and e-Table 1, respectively); …
… measurement of early inflammatory response (e-Table 2, Fig 3, and e-Table 1, respectively); …
[HTML][HTML] Readmission for acute exacerbation within 30 days of discharge is associated with a subsequent progressive increase in mortality risk in COPD patients: a …
Background and Objective Twenty per cent of chronic obstructive pulmonary disease (COPD)
patients are readmitted for acute exacerbation (AECOPD) within 30 days of discharge. The …
patients are readmitted for acute exacerbation (AECOPD) within 30 days of discharge. The …